In a recent issue of Drug Target Review you can find out more about upstream cell culture processes. The evolving role of three-dimensional in-vitro cell culture techniques in drug discovery and human iPSCs-derived functional cells are revolutionizing phenotypic drug discovery and development.
This In-Depth Focus is now available as an eBook. Get your free copy!
The first part of this webcast will feature a review of the basic principles of stirred-tank bioreactors. Ankita Desai of Eppendorf North America will explain factors that must be considered before and during the process.
Within the second part, Arie Reijerkerk and Farbod Famili from Ncardia, a stem cell drug discovery and development company, will provide insight into how the advent of human-induced pluripotent stem cell (hiPSC) technology has substantially expanded the availability of human cells for drug discovery.
Monday, September 16, 2019 at 9am EDT | 3pm CEST | 6:30pm IST
If you cannot join the live webinar, you can watch it on-demand at any time.
Facing many challenges towards commercialization of a therapeutic drug product, the company needs to be set up in a way to be sustainable throughout the clinical phase until revenue can be generated via commercial sales. Within this webinar, Bastian Leewis will illustrate and explain the approach chosen by MeiraGTx for some of the platform components.
In the second half of the webinar, Ankita Desai from Eppendorf North America will talk about bioprocess solutions for upstream bioprocess development and scale-up as an integral part of gene therapy product development.
Wednesday, September 25, 2019 at 10 am EDT | 4 pm CEST | 7:30 IST
If you cannot join the live webinar, you can watch it on-demand at any time.